• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical use of diazoxide and mechanism for its hyperglycemic effects.

作者信息

Graber A L, Porte D, Williams R H

出版信息

Diabetes. 1966 Mar;15(3):143-8. doi: 10.2337/diab.15.3.143.

DOI:10.2337/diab.15.3.143
PMID:4286307
Abstract
摘要

相似文献

1
Clinical use of diazoxide and mechanism for its hyperglycemic effects.二氮嗪的临床应用及其高血糖作用机制。
Diabetes. 1966 Mar;15(3):143-8. doi: 10.2337/diab.15.3.143.
2
Clinical experience with diazoxide.
Ann N Y Acad Sci. 1968 Apr 11;150(2):383-94. doi: 10.1111/j.1749-6632.1968.tb19063.x.
3
Control of hypoglycemia with diazoxide and hormones.
Ann N Y Acad Sci. 1968 Apr 11;150(2):406-14. doi: 10.1111/j.1749-6632.1968.tb19065.x.
4
Diazoxide therapy of intractable hypoglycemia.二氮嗪治疗顽固性低血糖症。
Ann N Y Acad Sci. 1968 Apr 11;150(2):442-54. doi: 10.1111/j.1749-6632.1968.tb19068.x.
5
Metabolic effects of diazoxide in normal subjects, patients with diabetes mellitus, and patients with organic hypoglycemia.二氮嗪对正常受试者、糖尿病患者及器质性低血糖患者的代谢作用。
Ann N Y Acad Sci. 1968 Apr 11;150(2):326-36. doi: 10.1111/j.1749-6632.1968.tb19058.x.
6
Clinical use of diazoxide and studies of the mechanism of its hyperglycemic effects in man.二氮嗪的临床应用及其对人体产生高血糖作用的机制研究。
Ann N Y Acad Sci. 1968 Apr 11;150(2):303-8. doi: 10.1111/j.1749-6632.1968.tb19055.x.
7
Diagnosis and medical management of insulinomas.
Annu Rev Med. 1979;30:313-29. doi: 10.1146/annurev.me.30.020179.001525.
8
Clinical and physiologic studies using diazoxide in the treatment of hypoglycemia.
Ann N Y Acad Sci. 1968 Apr 11;150(2):415-28. doi: 10.1111/j.1749-6632.1968.tb19066.x.
9
AO44: an improved hyperglycemic agent.AO44：一种改良的降血糖药物。
Metabolism. 1971 Apr;20(4):373-83. doi: 10.1016/0026-0495(71)90099-0.
10
Further studies on the metabolic effects of diazoxide.
J Pharmacol Exp Ther. 1965 Dec;150(3):455-62.

引用本文的文献

1
BYPASS-OMA: Hypoglycemic Hyperinsulinemic Nesidioblastosis after Gastric Bypass Surgery-A Case Report and Review of the Literature.胃旁路术后低血糖高胰岛素血症性胰岛细胞增殖症——一例报告并文献复习
Case Rep Endocrinol. 2022 Dec 22;2022:5472304. doi: 10.1155/2022/5472304. eCollection 2022.
2
Calcium Stimulation Test for Insulinoma Localization in an End-stage Renal Disease Patient on Diazoxide.接受二氮嗪治疗的终末期肾病患者胰岛素瘤定位的钙刺激试验
J Endocr Soc. 2020 Nov 27;5(2):bvaa185. doi: 10.1210/jendso/bvaa185. eCollection 2021 Feb 1.
3
Hyperpyruvaturia in experimental diabetes.
实验性糖尿病中的高丙酮尿症
J Physiol. 1967 Apr;189(2):237-46. doi: 10.1113/jphysiol.1967.sp008165.
4
Diabetes mellitus--current criteria for laboratory diagnosis.糖尿病——实验室诊断的现行标准。
Calif Med. 1969 Feb;110(2):107-13.
5
Ketotic (idiopathic glucagon unresponsive) hypoglycaemia: diazoxide effects.酮症性（特发性胰高血糖素无反应性）低血糖症：二氮嗪的作用。
Arch Dis Child. 1972 Aug;47(254):544-9. doi: 10.1136/adc.47.254.544.
6
Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy.口服二氮嗪成功用于治疗重度妊娠毒血症。
Br Med J. 1972 Jun 3;2(5813):568-70. doi: 10.1136/bmj.2.5813.568.
7
Studies on the mechanism of xylitol-induced insulin secretion in dogs. Effect of its infusion into the pancreatic artery, and the inhibition by epinephrine and diazoxide of xylitol-induced hyperinsulinaemia.
Diabetologia. 1969 Aug;5(4):248-57. doi: 10.1007/BF01212093.
8
[Insulin secretion in vitro. II. Inhibition of glucose induced insulin release by diazoxide].
Diabetologia. 1966 Dec;2(4):269-76. doi: 10.1007/BF01268185.
9
[Diazoxide: mechanism of its hyperglycemic action and therapeutic possibilities].[二氮嗪：其高血糖作用机制及治疗潜力]
Acta Diabetol Lat. 1969 Oct-Dec;6(4):844-55. doi: 10.1007/BF01548090.
10
Hormonal control of carbohydrate and lipid metabolism and drug induced alterations.碳水化合物和脂质代谢的激素调控以及药物引起的改变。
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968;259(2):117-48. doi: 10.1007/BF00537742.